SCHEMBL20126040

SCHEMBL20126040

C=CC(=O)N(CCCCCC)CCC(=O)OCC

nearest known ligand 0.55

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ZDHHC20 Q5W0Z9 3/20 0.55
ZDHHC2 Q9UIJ5 1/20 0.55
TSHR P16473 2/20 0.46
DNM1 Q05193 1/20 0.42
KDM5A P29375 2/20 0.42
DGKA P23743 1/20 0.41
MAPT P10636 1/20 0.40
ALDH1A1 P00352 1/20 0.39
LMNA P02545 1/20 0.39
PAM P19021 2/20 0.38
CCKBR P32239 1/20 0.38
CYP1A2 P05177 1/20 0.38
FAAH O00519 3/20 0.37
HPGD P15428 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20125995 0.94 ZDHHC20 (0.47) ZDHHC20ZDHHC2TSHRDNM1KDM5A
SCHEMBL20125970 0.90 ZDHHC20 (0.54) ZDHHC20ZDHHC2TSHRDNM1KDM5A
SCHEMBL20125950 0.90 ZDHHC20 (0.54) ZDHHC20ZDHHC2TSHRDNM1DGKA
SCHEMBL23420042 0.90 ZDHHC20 (0.54) ZDHHC20ZDHHC2TSHRDNM1DGKA
SCHEMBL20125977 0.90 ZDHHC20 (0.54) ZDHHC20ZDHHC2TSHRDNM1KDM5A
SCHEMBL20125991 0.88 ZDHHC20 (0.39) ZDHHC20ZDHHC2TSHRALDH1A1LMNA
SCHEMBL20125976 0.87 ZDHHC20 (0.50) ZDHHC20ZDHHC2TSHRDNM1DGKA
SCHEMBL23422066 0.87 ZDHHC20 (0.50) ZDHHC20ZDHHC2TSHRDNM1DGKA
SCHEMBL13411258 0.87 ZDHHC20 (0.56) ZDHHC20ZDHHC2TSHRDNM1DGKA
SCHEMBL13411262 0.87 ZDHHC20 (0.56) ZDHHC20ZDHHC2TSHRDNM1DGKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230135413-A1 CURABLE WATER-BASED COMPOSITION, ACTIVE-ENERGY-RAY-CURABLE WATER-BASED COMPOSITION, ACTIVE-ENERGY-RAY-CURABLE WATER-BASED INK, STORED CONTAINER, TWO-DIMENSIONAL OR THREE-DIMENSIONAL IMAGE FORMING APPARATUS, TWO-DIMENSIONAL OR THREE-DIMENSIONAL IMAGE FORMING METHOD, CURED PRODUCT, AND DECORATED BODY RICOH COMPANY, LTD. (JP) 2023-05-04 US disclosed
US-20230135413-A1 CURABLE WATER-BASED COMPOSITION, ACTIVE-ENERGY-RAY-CURABLE WATER-BASED COMPOSITION, ACTIVE-ENERGY-RAY-CURABLE WATER-BASED INK, STORED CONTAINER, TWO-DIMENSIONAL OR THREE-DIMENSIONAL IMAGE FORMING APPARATUS, TWO-DIMENSIONAL OR THREE-DIMENSIONAL IMAGE FORMING METHOD, CURED PRODUCT, AND DECORATED BODY RICOH COMPANY, LTD. (JP) 2023-05-04 US disclosed
US-11529302-B2 Composition, artificial nail composition, nail decoration material, artificial nail, stored container, image forming apparatus, and image forming method RICOH COMPANY, LTD. (JP) 2022-12-20 US disclosed
US-20210155814-A1 ACTIVE-ENERGY-RAY-CURABLE AQUEOUS COMPOSITION, ACTIVE-ENERGY-RAY-CURABLE AQUEOUS INK, STORED CONTAINER, IMAGE FORMING APPARATUS, IMAGE FORMING METHOD, CURED PRODUCT, AND DECORATED PRODUCT RICOH COMPANY, LTD. (JP) 2021-05-27 US disclosed
US-20210061929-A1 ACTIVE-ENERGY-RAY-CURABLE COMPOSITION, ACTIVE-ENERGY-RAY-CURABLE INK, COMPOSITION STORED CONTAINER, TWO-DIMENSIONAL OR THREE-DIMENSIONAL IMAGE FORMING METHOD AND APPARATUS, CURED PRODUCT, AND DECORATED PRODUCT RICOH COMPANY, LTD. (JP) 2021-03-04 US disclosed
US-10781325-B2 Curable composition, curable ink, accommodating container, image forming device, image forming method, cured matter, and acrylamide compound RICOH COMPANY, LTD. (JP) 2020-09-22 US disclosed
US-20200038310-A1 COMPOSITION, ARTIFICIAL NAIL COMPOSITION, NAIL DECORATION MATERIAL, ARTIFICIAL NAIL, STORED CONTAINER, IMAGE FORMING APPARATUS, AND IMAGE FORMING METHOD RICOH COMPANY, LTD. (JP) 2020-02-06 US disclosed
US-20200038309-A1 COMPOSITION, ARTIFICIAL NAIL COMPOSITION, NAIL DECORATION MATERIAL, ARTIFICIAL NAIL, STORED CONTAINER, IMAGE FORMING APPARATUS, AND IMAGE FORMING METHOD RICOH COMPANY, LTD. (JP) 2020-02-06 US disclosed
US-20180127607-A1 CURABLE COMPOSITION, CURABLE INK, ACCOMMODATING CONTAINER, IMAGE FORMING DEVICE, IMAGE FORMING METHOD, CURED MATTER, AND ACRYLAMIDE COMPOUND RICOH COMPANY, LTD. (JP) 2018-05-10 US disclosed
US-20180127607-A1 CURABLE COMPOSITION, CURABLE INK, ACCOMMODATING CONTAINER, IMAGE FORMING DEVICE, IMAGE FORMING METHOD, CURED MATTER, AND ACRYLAMIDE COMPOUND RICOH COMPANY, LTD. (JP) 2018-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10781325-B2 Curable composition, curable ink, accommodating container, image forming device, image forming method, cured matter, and acrylamide compound CRYAA, CDKN1A, ACR ZDHHC20 3181/4885ZDHHC2 3342/4885TSHR 4587/4885
US-20180127607-A1 CURABLE COMPOSITION, CURABLE INK, ACCOMMODATING CONTAINER, IMAGE FORMING DEVICE, IMAGE FORMING METHOD, CURED MATTER, AND ACRYLAMIDE COMPOUND CRYAA, CDKN1A, ACR ZDHHC20 3181/4885ZDHHC2 3342/4885TSHR 4587/4885
US-20200038309-A1 COMPOSITION, ARTIFICIAL NAIL COMPOSITION, NAIL DECORATION MATERIAL, ARTIFICIAL NAIL, STORED CONTAINER, IMAGE FORMING APPARATUS, AND IMAGE FORMING METHOD NACA, PIK3C3, DPM1 ZDHHC20 3546/4885ZDHHC2 3361/4885TSHR 1601/4885
US-20200038310-A1 COMPOSITION, ARTIFICIAL NAIL COMPOSITION, NAIL DECORATION MATERIAL, ARTIFICIAL NAIL, STORED CONTAINER, IMAGE FORMING APPARATUS, AND IMAGE FORMING METHOD NACA, PIK3C3, ACR ZDHHC20 3530/4885ZDHHC2 3485/4885TSHR 1730/4885
US-11529302-B2 Composition, artificial nail composition, nail decoration material, artificial nail, stored container, image forming apparatus, and image forming method NACA, PIK3C3, ACR ZDHHC20 3530/4885ZDHHC2 3485/4885TSHR 1730/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.